Jiangsu NHWA Pharmaceutical (002262.SZ): Metronidazole Tablets Passed Generic Consistency Evaluation.

On July 17th, Gelunhui reported that Jiangsu NHWA Pharmaceutical (002262.SZ) announced that it recently received the "Drug Supplementary Application Approval Notice" for Liruzole Tablets issued and approved by the National Medical Products Administration, approving the consistency evaluation of the drug as a generic drug in terms of its quality and efficacy. Liruzole Tablets are used to prolong the life of patients with amyotrophic lateral sclerosis (ALS) or delay the time until mechanical ventilation support is needed. The company has invested approximately 5.3 million yuan in the consistency evaluation project of this product.

Gelonghui FinanceJul 17 04:43 ET

Is Now The Time To Put Jiangsu Nhwa Pharmaceutical (SZSE:002262) On Your Watchlist?

Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks' without any revenue, let alone profit. Sometimes these stories can cloud the minds

Simply Wall StJul 3 19:13 ET

Jiangsu NHWA pharmaceutical (002262.SZ) mainly produces a series of drugs related to the central nervous system.

Jiangsu NHWA Pharmaceutical (002262.SZ) stated on the investor interaction platform on June 25 that the company's main products are a series of central nervous system related drugs. The pricing of controlled anesthetic drugs and Class I psychotropic drugs is controlled by relevant national regulatory departments, while prices of other varieties are determined by market conditions. Product prices have remained relatively stable.

Gelonghui FinanceJun 25 05:16 ET

Nhwa Pharmaceutical's Penehyclidine Hydrochloride Injection Passes Regulatory Testing

Jiangsu Nhwa Pharmaceutical's (SHE:002262) penehyclidine hydrochloride injection passed the consistency evaluation of China's National Medical Products Administration, according to a Wednesday filing

MT NewswiresJun 20 00:00 ET

Nhwa Pharmaceutical Gets Registration Certificate for Pregabalin Capsules

Jiangsu Nhwa Pharmaceutical (SHE:002262) received a drug registration certificate from China's National Medical Products Administration for its pregabalin capsules, according to the company's filing o

MT NewswiresJun 19 23:57 ET

Jiangsu NHWA Pharmaceutical (002262.SZ): The consistency evaluation of the generic levofloxacin hydrochloride injection passed.

On June 19, Glonhecom reported that Jiangsu NHWA Pharmaceutical (002262.SZ) recently received the "Drug Supplementary Application Approval Notice" for the injection of hydrochloride propamine (specification of 1ml:0.5mg) from the National Medical Products Administration, approving the quality and efficacy consistency evaluation of this specification drug for generic drugs. Hydrochloride propamine injection is a selective anticholinergic drug. (1) It is used for pre-anesthesia to inhibit salivary and airway gland secretion. (2) It is used for emergency treatment of organophosphorus pesticide poisoning and post-poisoning or maintenance of atropine after cholinesterase (ChE) aging.

Gelonghui FinanceJun 19 04:21 ET